| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | Chief Medical Officer | Stock Option (Right to Buy) | 108K | 08 Feb 2023 | Direct | ||
| Viridian Therapeutics, Inc.\DE | Chief Medical Officer | Common Stock | 0 | $21.00 | 17 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | 08 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 10 Feb 2023, 15:54 |
| VRDN | Viridian Therapeutics, Inc.\DE | 13 Jan 2023 | 6 | -$410K | 4 | Chief Medical Officer | 18 Jan 2023, 16:58 |
| VRDN | Viridian Therapeutics, Inc.\DE | 09 Jan 2023 | 6 | -$708K | 4 | Chief Medical Officer | 11 Jan 2023, 18:09 |
| VRDN | Viridian Therapeutics, Inc.\DE | 02 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 03 Feb 2022, 17:13 |